The Treatment of Adult Respiratory Distress Syndrome (ARDS) Using Extracorporeal Membrane Oxygenation (ECMO).
- Author:
Go Woon KIM
1
;
Eun Young CHOI
;
Sang Bum HONG
Author Information
- Publication Type:Original Article
- Keywords: Respiratory Distress Syndrome, Adult; Extracorporeal Membrane Oxygenation; Extracorporeal Circulation; Intensive Care Unit
- MeSH: Adult; Extracorporeal Circulation; Extracorporeal Membrane Oxygenation; Heart Failure; Humans; Influenza, Human; Intensive Care Units; Oxygen; Pandemics; Respiratory Distress Syndrome, Adult; Survival Rate; Ventilation
- From:Tuberculosis and Respiratory Diseases 2012;72(1):1-7
- CountryRepublic of Korea
- Language:Korean
- Abstract: Extracorporeal Membrane Oxygenation (ECMO) support to tissue oxygenation has been shown to improve survival in patients with life threatening respiratory distress syndrome or cardiac failure. Extracorporeal life support such as ECMO, including extracorporeal CO2 removal (ECCO2R), is used as temporary support until successful recovery of organs. A recently published multicentre randomized controlled trial, known as the CESAR (conventional ventilation or extracorporeal membrane oxygenation for severe adult respiratory failure) trial, was the first trial to demonstrate the utility of ECMO in acute respiratory distress syndrome (ARDS). During the 2009 influenza A (H1N1) pandemic, there were many reports of patients with severe ARDS related to H1N1 infection treated with ECMO. These reports revealed a high survival rate and effectiveness of ECMO. In this review, we explain the indication of ECMO clinical application, the practical types of ECMO, and complications associated with ECMO. In addition, we explain recent new ECMO technology and management of patients during ECMO support.
